Candriam Luxembourg S.C.A. »

Caribou Biosciences shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.9M 860k 5.73
2023-03-31 $418k 86k 4.89

More positions owned by Candriam Luxembourg S.C.A.

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Visa Com Cl A (V)
Gilead Sciences (GILD)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
Procter & Gamble Company (PG)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Caribou Biosciences

Partner Fund Management
Avidity Partners Management
Vanguard Group
Point72 Asset Management
Paradigm Biocapital Advisors
Elmwood Wealth Management
Bank of America Corporation
Dimensional Fund Advisors
Kynam Capital Management
Candriam Luxembourg S.C.A.
Rokos Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Maverick Capital
Jpmorgan Chase & Co

View all funds holding Caribou Biosciences